Express Scripts (NASDAQ: ESRX) announced its results for the third quarter on October 25, 2011. Let's take a closer look at the company's industry, financials, and commentary and see what steps you can take next.
Earnings and Revenue:
Wall Street watched as Express Scripts topped expectations with its latest EPS and revenue figures. The company reported adjusted net income of 79 cents/share versus the 78 cents/share estimate and revenues of $11.57 billion versus the $11.26 billion estimate. Revenue climbed 2.8% from the same period last year.
Last quarter marked the third in a row of rising net income. Revenue rose for a second quarter in a row as Express Scripts' sales grew 0.6% to $11.36 billion in the second quarter as well.
Income:
For the year, Express Scripts reported net income of $2.87/share. The company fell short of analysts' projections of $2.89/share. According to the reported number, the company's income rose 7.7% from last year's levels.
Official Comment:
"Our third quarter results reflect the continued execution of our business model and the value of fully aligning with clients," stated George Paz, chief executive officer and chairman. "We continue to invest robustly for the future, maintaining our focus on innovation, service and achieving optimal health outcomes. We are confident that these investments will create value for plan sponsors and patients and will continue to drive growth in shareholder value."
Industry:
With price/earnings growth of 1.1%, Express Scripts' industry, medical services, is expanding.
What to Do Next:
Now you can make a better-informed decision about whether to buy, sell or hold Express Scripts shares until the next earnings announcement. Whatever you do, be sure to check back in with us before the company's next earnings release for a full prep sheet, just like the one we did here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
